Abstract:Cancer is an important cause of death worldwide. The main types of cancer treatment are still surgery, chemotherapy and radiotherapy, and immunotherapy is becoming an important cancer treatment. Pyroptosis is a type of programmed cell death that accompanies an inflammatory response. This paper reviews the recent research progress in pyroptosis in tumors. Pyroptosis has been observed since 1986 and until recently has been recognized as programmed cell death mediated by GSDM family proteins. The molecular pathway of pyroptosis depends on the inflammasome-mediated caspase-1/GSDMD pathway, which is the canonical pathway, and the caspase-4/5/11/GSDMD pathway, which is the noncanonical pathway. Other pathways include caspase3/GSDME. Pyroptosis is a double-edged sword that is closely related to the tumor immune microenvironment. On the one hand, pyroptosis produces a chronic inflammatory environment, promotes the transition of normal cells to tumor cells, helps tumor cells achieve immune escape, and promotes tumor growth and metastasis. On the other hand, some tumor cell treatments can induce pyroptosis, which is a nonapoptotic form of cell death. Additionally, pyroptosis releases inflammatory molecules that promote lymphocyte recruitment and enhance the immune system's ability to kill tumor cells. With the advent of immunotherapy, pyroptosis has been shown to enhance the antitumor efficacy of immune checkpoint inhibitors. Some antineoplastic agents, such as chemotherapeutic agents, can also exert antineoplastic effects through the pyroptosis pathway. Pyroptosis, which is a programmed cell death mode, has been the focus of research in recent years, and the relationship between pyroptosis, tumors and tumor immunity has attracted attention, but there are still some questions to be answered regarding the specific mechanism. Further study of pyroptosis would aid in developing new antitumor therapies and has great clinical prospects.

Stem Cell‑mediated Modulation of Pyroptosis Contributes to Tissue Repair in Noninfective Inflammatory‑related Diseases (Review)

Role of pyroptosis in the pathogenesis and treatment of diseases

Research Progress of the Relationship Between Pyroptosis and Disease

Pyroptosis in health and disease: mechanisms, regulation and clinical perspective

Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment

Pyroptosis in inflammatory diseases and cancer

Pyroptosis-Induced Inflammation and Tissue Damage

The role of pyroptosis in inflammatory diseases.

Cell pyroptosis in health and inflammatory diseases

Pyroptosis As a Double-Edged Sword: the Pathogenic and Therapeutic Roles in Inflammatory Diseases and Cancers

Pyroptosis: a new paradigm of cell death for fighting against cancer

Pyroptosis: shedding light on the mechanisms and links with cancers

Reactive Oxygen Species‐Mediated Pyroptosis with the Help of Nanotechnology: Prospects for Cancer Therapy

Emerging pyroptosis-engineered nanobiotechnologies regulate cancers and inflammatory diseases: A double-edged sword

Research Progresses of Molecular Mechanism of Pyroptosis and Its Related Diseases

The regulatory role and therapeutic application of pyroptosis in musculoskeletal diseases

Role of pyroptosis in inflammation and cancer

Pyroptosis: A New Frontier in Cancer

The Regulation of Pyroptosis by Post-Translational Modifications: Molecular Mechanisms and Therapeutic Targets

Pyroptosis Provides New Strategies for the Treatment of Cancer

Role of Pyroptosis in Traumatic Brain and Spinal Cord Injuries